Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Radiation Therapy and Dosimetry, Lung Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, and Esophageal Cancer Research and Treatment.
Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres
Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms
Orthotopic Glioblastoma Models for Evaluation of the Clinical Target Volume Concept
Randomisierte Studie zum Vergleich von Nebenwirkungen nach Protonen- versus Photonen-Strahlentherapie bei Patienten mit fortgeschrittenem nichtkleinzelligen Bronchialkarzinom
Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy
Value of PET imaging for radiation therapy
Modelling of late side-effects following cranial proton beam therapy
Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses
Value of PET imaging for radiation therapy
Correction to: Value of PET imaging for radiation therapy
Neurocognitive function and quality of life after proton beam therapy for brain tumour patients
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer
High-precision image-guided proton irradiation of mouse brain sub-volumes
Multi-modality bedding platform for combined imaging and irradiation of mice
Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
Specific requirements for translation of biological research into clinical radiation oncology
A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
Combined tumor plus nontumor interim FDG‐PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer
Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens
Dose–volume predictors of early esophageal toxicity in non-small cell lung cancer patients treated with accelerated-hyperfractionated radiotherapy
Prognostic Value of Standardized Uptake Ratio in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma
Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios
Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting
Proton radiography for inline treatment planning and positioning verification of small animals
Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy
Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy
PORTAF – postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation – study protocol for a randomized controlled trial
Precise image-guided irradiation of small animals: a flexible non-profit platform